Need help finding what you are looking for?
Contact Us
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1912171
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1912171
Oncolytic Viral Therapy Market Insights, Competitive Landscape, and Market Forecast - 2033
PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
The global Oncolytic Viral Therapy Market is set for substantial growth, projected to reach USD 297.8 million in 2026 and surge to USD 1,157.3 million by 2033, reflecting a CAGR of 21.4% during the forecast period. Oncolytic viral therapy is an advanced approach in oncology that uses genetically engineered viruses to selectively infect and destroy cancer cells while activating the patient's immune system. This novel therapeutic approach offers hope for patients with treatment-resistant cancers and is gradually reshaping the landscape of cancer care worldwide.
Market Insights
The oncolytic viral therapy market is expanding rapidly due to rising incidences of cancer, growing adoption of immuno-oncology treatments, and increasing investments in biotechnology research. Clinical trials are being conducted across multiple cancer types, including melanoma, glioblastoma, pancreatic cancer, and lung cancer, highlighting the versatility of these therapies. Collaboration between biotech companies and research institutions is further enhancing innovation, focusing on improving viral delivery mechanisms, safety profiles, and therapeutic efficacy.
Market Drivers
Several factors are fueling the growth of the oncolytic viral therapy market:
- Rising Cancer Prevalence: The global increase in cancer cases is driving demand for novel therapies that go beyond conventional chemotherapy and radiation.
- Technological Advancements: Innovations in viral vector engineering and genetic modification have made therapies more targeted and effective.
- Patient Preference: There is increasing demand for treatments with fewer side effects compared to traditional therapies.
- Regulatory Approvals: Approvals of breakthrough therapies like Talimogene laherparepvec (T-VEC) have validated the effectiveness of oncolytic viral therapies and boosted market confidence.
Business Opportunities
The market offers multiple avenues for growth and innovation:
- Combination Therapies: Companies are exploring oncolytic viruses in combination with immune checkpoint inhibitors or CAR-T therapies to maximize treatment efficacy.
- Emerging Markets: Rising healthcare expenditure and growing awareness of cancer treatment options present significant expansion opportunities.
- Personalized Medicine: Tailoring therapies to individual patients can improve outcomes and increase market adoption.
- R&D and Collaboration: Partnerships between biotech firms, pharmaceutical companies, and academic institutions are driving pipeline growth and commercialization potential.
Regional Analysis
- North America: Dominates the market due to high healthcare spending, strong biotechnology infrastructure, and active clinical trials.
- Europe: Shows steady growth supported by research initiatives and government programs promoting advanced oncology therapies.
- Asia-Pacific: Emerging as a high-potential market due to increasing cancer incidence, improving healthcare infrastructure, and rising awareness of novel therapies.
- Latin America & Middle East/Africa: Expected to witness gradual growth as access to advanced oncology treatments improves.
Key Players
Key players shaping the oncolytic viral therapy market include:
- Amgen Inc.
- Oncorus Inc.
- Sorrento Therapeutics Inc.
- PsiOxus Therapeutics Ltd.
- Merck & Co. Inc.
- Targovax ASA
- Viralytics Ltd.
- Transgene SA
- Celyad Oncology SA
- Iovance Biotherapeutics Inc.
Market Segmentation
- By Type:
- Adenovirus
- Herpes Simplex Virus
- Reovirus
- Vaccinia Virus
- Others
- By Application:
- Melanoma
- Glioblastoma
- Pancreatic Cancer
- Lung Cancer
- Other Cancer Types
- By End User:
- Hospitals & Clinics
- Cancer Research Institutes
- Academic & Government Research Laboratories
Table of Contents
1. Executive Summary
- 1.1. Global Oncolytic Viral Therapy Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 3.1. Global Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 3.1.1. Herpes simplex virus
- 3.1.2. Adenovirus
- 3.1.3. Vaccinia virus
- 3.1.4. Reovirus
- 3.1.5. Measles virus
- 3.1.6. Others
- 3.2. Global Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 3.2.1. Melanoma
- 3.2.2. Breast cancer
- 3.2.3. Head and neck cancer
- 3.2.4. Bladder Cancer
- 3.2.5. Prostate Cancer
- 3.2.6. Lung Cancer
- 3.2.7. Others
- 3.3. Global Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 3.3.1. Commercial
- 3.3.2. Pipeline Phase
- 3.3.3. Pre-clinical
- 3.4. Global Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 3.4.1. Hospital Pharmacies
- 3.4.2. Retail Pharmacies
- 3.4.3. Online Pharmacies
- 3.5. Global Oncolytic Viral Therapy Market Outlook, by Region, Value (US$ Mn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 4.1. North America Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 4.1.1. Herpes simplex virus
- 4.1.2. Adenovirus
- 4.1.3. Vaccinia virus
- 4.1.4. Reovirus
- 4.1.5. Measles virus
- 4.1.6. Others
- 4.2. North America Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 4.2.1. Melanoma
- 4.2.2. Breast cancer
- 4.2.3. Head and neck cancer
- 4.2.4. Bladder Cancer
- 4.2.5. Prostate Cancer
- 4.2.6. Lung Cancer
- 4.2.7. Others
- 4.3. North America Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 4.3.1. Commercial
- 4.3.2. Pipeline Phase
- 4.3.3. Pre-clinical
- 4.4. North America Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 4.4.1. Hospital Pharmacies
- 4.4.2. Retail Pharmacies
- 4.4.3. Online Pharmacies
- 4.5. North America Oncolytic Viral Therapy Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 4.5.1. U.S. Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 4.5.2. U.S. Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 4.5.3. U.S. Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 4.5.4. U.S. Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 4.5.5. Canada Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 4.5.6. Canada Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 4.5.7. Canada Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 4.5.8. Canada Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 5.1. Europe Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 5.1.1. Herpes simplex virus
- 5.1.2. Adenovirus
- 5.1.3. Vaccinia virus
- 5.1.4. Reovirus
- 5.1.5. Measles virus
- 5.1.6. Others
- 5.2. Europe Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 5.2.1. Melanoma
- 5.2.2. Breast cancer
- 5.2.3. Head and neck cancer
- 5.2.4. Bladder Cancer
- 5.2.5. Prostate Cancer
- 5.2.6. Lung Cancer
- 5.2.7. Others
- 5.3. Europe Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 5.3.1. Commercial
- 5.3.2. Pipeline Phase
- 5.3.3. Pre-clinical
- 5.4. Europe Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Online Pharmacies
- 5.5. Europe Oncolytic Viral Therapy Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 5.5.1. Germany Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.2. Germany Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.3. Germany Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.4. Germany Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.5. Italy Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.6. Italy Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.7. Italy Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.8. Italy Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.9. France Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.10. France Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.11. France Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.12. France Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.13. U.K. Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.14. U.K. Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.15. U.K. Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.16. U.K. Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.17. Spain Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.18. Spain Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.19. Spain Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.20. Spain Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.21. Russia Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.22. Russia Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.23. Russia Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.24. Russia Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.5.25. Rest of Europe Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 5.5.26. Rest of Europe Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 5.5.27. Rest of Europe Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 5.5.28. Rest of Europe Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 6.1.1. Herpes simplex virus
- 6.1.2. Adenovirus
- 6.1.3. Vaccinia virus
- 6.1.4. Reovirus
- 6.1.5. Measles virus
- 6.1.6. Others
- 6.2. Asia Pacific Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 6.2.1. Melanoma
- 6.2.2. Breast cancer
- 6.2.3. Head and neck cancer
- 6.2.4. Bladder Cancer
- 6.2.5. Prostate Cancer
- 6.2.6. Lung Cancer
- 6.2.7. Others
- 6.3. Asia Pacific Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 6.3.1. Commercial
- 6.3.2. Pipeline Phase
- 6.3.3. Pre-clinical
- 6.4. Asia Pacific Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 6.4.1. Hospital Pharmacies
- 6.4.2. Retail Pharmacies
- 6.4.3. Online Pharmacies
- 6.5. Asia Pacific Oncolytic Viral Therapy Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 6.5.1. China Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.2. China Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.3. China Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.4. China Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.5.5. Japan Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.6. Japan Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.7. Japan Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.8. Japan Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.5.9. South Korea Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.10. South Korea Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.11. South Korea Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.12. South Korea Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.5.13. India Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.14. India Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.15. India Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.16. India Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.5.17. Southeast Asia Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.18. Southeast Asia Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.19. Southeast Asia Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.20. Southeast Asia Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.5.21. Rest of SAO Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 6.5.22. Rest of SAO Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 6.5.23. Rest of SAO Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 6.5.24. Rest of SAO Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 7.1. Latin America Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 7.1.1. Herpes simplex virus
- 7.1.2. Adenovirus
- 7.1.3. Vaccinia virus
- 7.1.4. Reovirus
- 7.1.5. Measles virus
- 7.1.6. Others
- 7.2. Latin America Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 7.2.1. Melanoma
- 7.2.2. Breast cancer
- 7.2.3. Head and neck cancer
- 7.2.4. Bladder Cancer
- 7.2.5. Prostate Cancer
- 7.2.6. Lung Cancer
- 7.2.7. Others
- 7.3. Latin America Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 7.3.1. Commercial
- 7.3.2. Pipeline Phase
- 7.3.3. Pre-clinical
- 7.4. Latin America Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies
- 7.5. Latin America Oncolytic Viral Therapy Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 7.5.1. Brazil Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 7.5.2. Brazil Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 7.5.3. Brazil Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 7.5.4. Brazil Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 7.5.5. Mexico Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 7.5.6. Mexico Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 7.5.7. Mexico Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 7.5.8. Mexico Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 7.5.9. Argentina Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 7.5.10. Argentina Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 7.5.11. Argentina Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 7.5.12. Argentina Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 7.5.13. Rest of LATAM Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 7.5.14. Rest of LATAM Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 7.5.15. Rest of LATAM Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 7.5.16. Rest of LATAM Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oncolytic Viral Therapy Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Oncolytic Viral Therapy Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
- 8.1.1. Herpes simplex virus
- 8.1.2. Adenovirus
- 8.1.3. Vaccinia virus
- 8.1.4. Reovirus
- 8.1.5. Measles virus
- 8.1.6. Others
- 8.2. Middle East & Africa Oncolytic Viral Therapy Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 8.2.1. Melanoma
- 8.2.2. Breast cancer
- 8.2.3. Head and neck cancer
- 8.2.4. Bladder Cancer
- 8.2.5. Prostate Cancer
- 8.2.6. Lung Cancer
- 8.2.7. Others
- 8.3. Middle East & Africa Oncolytic Viral Therapy Market Outlook, by Development Stage, Value (US$ Mn), 2020-2033
- 8.3.1. Commercial
- 8.3.2. Pipeline Phase
- 8.3.3. Pre-clinical
- 8.4. Middle East & Africa Oncolytic Viral Therapy Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Online Pharmacies
- 8.5. Middle East & Africa Oncolytic Viral Therapy Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 8.5.1. GCC Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 8.5.2. GCC Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 8.5.3. GCC Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 8.5.4. GCC Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 8.5.5. South Africa Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 8.5.6. South Africa Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 8.5.7. South Africa Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 8.5.8. South Africa Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 8.5.9. Egypt Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 8.5.10. Egypt Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 8.5.11. Egypt Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 8.5.12. Egypt Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 8.5.13. Nigeria Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 8.5.14. Nigeria Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 8.5.15. Nigeria Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 8.5.16. Nigeria Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 8.5.17. Rest of Middle East Oncolytic Viral Therapy Market Outlook, by Product Type, 2020-2033
- 8.5.18. Rest of Middle East Oncolytic Viral Therapy Market Outlook, by Application, 2020-2033
- 8.5.19. Rest of Middle East Oncolytic Viral Therapy Market Outlook, by Development Stage, 2020-2033
- 8.5.20. Rest of Middle East Oncolytic Viral Therapy Market Outlook, by Distribution Channel, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Amgen Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Oncolytics Biotech Inc.
- 9.4.3. Replimune Group Inc.
- 9.4.4. Sorrento Therapeutics Inc.
- 9.4.5. Transgene SA
- 9.4.6. PsiOxus Therapeutics Ltd.
- 9.4.7. SillaJen Inc.
- 9.4.8. Targovax ASA
- 9.4.9. Genelux Corporation
- 9.4.10. Vyriad Inc.
- 9.4.1. Amgen Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.